Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Shares Outstanding (Diluted Average) (2017 - 2025)

Historic Shares Outstanding (Diluted Average) for CV Sciences (CVSI) over the last 9 years, with Q3 2025 value amounting to $184.3 million.

  • CV Sciences' Shares Outstanding (Diluted Average) rose 109.9% to $184.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $184.3 million, marking a year-over-year increase of 109.9%. This contributed to the annual value of $138.0 million for FY2022, which is 2802.62% up from last year.
  • According to the latest figures from Q3 2025, CV Sciences' Shares Outstanding (Diluted Average) is $184.3 million, which was up 109.9% from $184.3 million recorded in Q2 2025.
  • Over the past 5 years, CV Sciences' Shares Outstanding (Diluted Average) peaked at $184.3 million during Q1 2025, and registered a low of $104.5 million during Q1 2021.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $146.8 million, with a median of $152.1 million in 2023.
  • As far as peak fluctuations go, CV Sciences' Shares Outstanding (Diluted Average) skyrocketed by 3428.95% in 2022, and later surged by 109.9% in 2025.
  • Quarter analysis of 5 years shows CV Sciences' Shares Outstanding (Diluted Average) stood at $107.8 million in 2021, then rose by 28.03% to $138.0 million in 2022, then grew by 12.0% to $154.6 million in 2023, then increased by 17.89% to $182.3 million in 2024, then grew by 1.1% to $184.3 million in 2025.
  • Its last three reported values are $184.3 million in Q3 2025, $184.3 million for Q2 2025, and $184.3 million during Q1 2025.